Anagrelide Hydrochloride Capsule shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Nov 19, 2025 · last update Nov 19, 2025
Manufacturers: Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Anagrelide Hydrochloride, Capsule, 1 mg (NDC 0172-5240-60) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Nov 19, 2025 Updated Nov 19, 2025 Discontinued Nov 19, 2025 |
| Anagrelide Hydrochloride, Capsule, 0.5 mg (NDC 0172-5241-60) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Nov 19, 2025 Updated Nov 19, 2025 Discontinued Nov 19, 2025 |